(MedPage Today) — The inflammation suppressant colchicine could show more promise in transcatheter aortic valve replacement (TAVR) — if not for excess strokes, as seen in one small randomized study.
In the Co-STAR double-blind trial, periprocedural…
Source link : https://www.medpagetoday.com/cardiology/pci/116548
Author :
Publish date : 2025-07-17 17:10:00
Copyright for syndicated content belongs to the linked Source.
